Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 • 3,543 citations
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 • 2,117 citations
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997 • 1,651 citations
Etanercept Therapy in Rheumatoid Arthritis
1999 • 1,407 citations
Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis
1994 • 705 citations
HEALTHY CARRIAGE OF STAPHYLOCOCCUS AUREUS : ITS PREVALENCE AND IMPORTANCE
1963 • 545 citations
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
1996 • 439 citations
The role of CpG motifs in innate immunity
2000 • 349 citations
[Etanercept for therapy of rheumatoid arthritis].
2005 • 344 citations
HEALTHY CARRIAGE OF STAPHYLOCOCCUS AUREUS: ITS PREVALENCE AND IMPORTANCE1
1963 • 296 citations
Activation of human B cells by phosphorothioate oligodeoxynucleotides.
1996 • 292 citations
Carriage ofStaphylococcus aureusin random samples of a normal population
1967 • 175 citations
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms.
1998 • 167 citations
DNA activates human immune cells through a CpG sequence‐dependent manner
1999 • 156 citations
TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus.
1998 • 101 citations